Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Comfrey (Symphytum officinale)
A traditional poultice herb containing unsaturated pyrrolizidine alkaloids, which are hepatotoxic and carcinogenic. Comfrey is described here so that it can be SCREENED — it is never recommended, and internal use has caused fatal hepatic veno-occlusive disease.
Botanical safety warning
Do not take comfrey by mouth: its pyrrolizidine alkaloids can cause serious liver injury. Some regulated skin products use specified preparations with controlled alkaloid content; their instructions do not apply to oral or homemade comfrey products. This page does not endorse a self-directed dose.
What the evidence says
Comfrey doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality studies published 2000–2026.
Based on 4 studies
Study base
4 studies indexedBy outcome
Every outcome below: Too few graded studies.
Scores at the floor for internal use. What controlled evidence exists concerns topical preparations; the oral literature is toxicological — hepatic veno-occlusive disease, cirrhosis and death from pyrrolizidine alkaloids.
No trials currently enrolling · 1 completed on ClinicalTrials.gov
Registered trials show research momentum for Comfrey, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Nov 2026
Comfrey (Symphytum officinale) has a long history as a topical poultice for sprains and bruises — the name 'knitbone' records that use.
Its hazard is chemical rather than traditional: the plant contains unsaturated pyrrolizidine alkaloids, which are bioactivated in the liver to pyrrolic esters that damage the sinusoidal endothelium. The result is hepatic veno-occlusive disease, and case reports describe cirrhosis and death after oral use.
The same alkaloid class caused endemic outbreaks in Jamaica, India and Afghanistan through contaminated cereals and bush teas. It is described so that it can be recognised and avoided, not as an option: it is linked to no goal and is left out of every recommendation.
A reader who scans a product or types the name is told what it is, instead of being told it could not be identified.
Hepatic CYP450 converts the unsaturated alkaloids to reactive pyrrolic esters, which bind protein and DNA and injure the hepatic sinusoidal endothelium.
Endothelial injury obstructs the small hepatic veins, producing the syndrome that has proved fatal after oral comfrey.
Avoid — pyrrolizidine alkaloids cross the placenta and are hepatotoxic and genotoxic.
Avoid — pyrrolizidine alkaloids pass into breast milk and an infant's liver is the target organ.
Avoid — the injury mechanism is hepatic and a damaged liver has less reserve.
Avoid — never give this herb to a child.
Injury is hepatic and additive with any other agent that damages the liver.
Induction increases conversion of the alkaloids to their reactive metabolites.
Tip: Seek medical assessment — these are features of veno-occlusive disease
Tip: Emergency medical care — this has been fatal
The current evidence for Comfrey is insufficient to assign an evidence score, based on 4 indexed studies. A traditional poultice herb containing unsaturated pyrrolizidine alkaloids, which are hepatotoxic and carcinogenic. Comfrey is described here so that it can be SCREENED — it is never recommended, and internal use has caused fatal hepatic veno-occlusive disease. Representative study: PMID 32105669.
Dosing for Comfrey: No appropriate oral dose. The herb is described here so it can be screened, not taken.
Timing is flexible for Comfrey — consistent daily use matters more than the time of day. No oral dose is appropriate; no timing guidance is given.
No consumer dose of Comfrey is endorsed, so there is no dose at which it can be called safe. Talk to a healthcare provider before taking it. Selected serious risks: abdominal pain, nausea, ascites, progressive liver failure. How often they occur is not established for all of them. Use caution if any of these apply to you: Any liver disease — do not take; the alkaloids are a known hepatotoxin; Pregnancy — do not take; the alkaloids cross the placenta; Breastfeeding — do not take; the alkaloids pass into breast milk.
Psyllium Husk
HelpedGel-forming soluble fiber that lowers LDL cholesterol, regulates blood sugar, and promotes digestive regularity.
St. John's Wort
HelpedModulates serotonin, dopamine, and norepinephrine; studied for mood, with trials in mild-to-moderate depression comparing it to SSRIs — requires drug-interaction caution.
Aged Garlic Extract
HelpedOdorless garlic extract with evidence for blood pressure and cardiovascular markers, and one trial reporting milder colds and flu.
Ashwagandha
Too few graded studiesReduces cortisol and anxiety while improving sleep quality and physical recovery in stressed adults.
Edited by Dr. Baher Al Hakim · Last updated November 2026 · evidence from 4 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.